SQUAMOUS CELL CARCINOMA OF THE HYPOPHARYNX
Clinical trials for SQUAMOUS CELL CARCINOMA OF THE HYPOPHARYNX explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA OF THE HYPOPHARYNX trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF THE HYPOPHARYNX, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
MRI-Guided radiation boost shows promise in head and neck cancer trial
Disease control OngoingThis study tests whether giving an extra dose of radiation to oxygen-poor (hypoxic) areas of head and neck tumors can improve treatment response. About 91 adults with advanced squamous cell cancer of the throat or voice box will receive standard chemo-radiation with or without th…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HYPOPHARYNX
Phase: PHASE2 • Sponsor: Regina Elena Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could fewer radiation sessions after surgery improve quality of life for head and neck cancer patients?
Disease control OngoingThis study tests a shorter, more intense course of radiation therapy (hypofractionated IMRT) given after surgery for head and neck cancer. The goal is to see if it is safe and if it can help patients maintain better swallowing function compared to the standard longer radiation sc…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HYPOPHARYNX
Phase: PHASE1, PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New chemo combo aims to help laryngeal cancer patients keep their voice
Disease control OngoingThis Phase 3 trial tests whether giving a three-drug chemotherapy regimen (docetaxel, cisplatin, and fluorouracil) before radiotherapy helps people with advanced laryngeal or hypopharyngeal cancer avoid losing their voice box. The standard approach is to give cisplatin during rad…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HYPOPHARYNX
Phase: PHASE3 • Sponsor: Groupe Oncologie Radiotherapie Tete et Cou • Aim: Disease control
Last updated Jun 26, 2026 12:59 UTC